Estamos no ar no ! Saiba mais
SLGCW

SomaLogic Warrant

Deslistada

SLGCW foi retirado da bolsa em 5 de janeiro de 2024.

 

Sobre: SomaLogic is a commercial-stage proteomics company. It operates as a protein biomarker discovery and clinical diagnostics company that develops slow off-rate modified aptamers, which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein. The Somamers/SomaScan technology enables researchers to analyze various types of biological samples for protein biomarker signatures, which can be utilized in drug discovery and development.

Funcionários: 451

Notícias

Positiva
Neutra
Negativa
Sentimento 3 meses
Positiva 0%
Neutra 0%
Negativa 0%

Não recebemos notícias recentes sobre SLGCW

Gráficos de preços implementados com Lightweight Charts™